BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.
Novartis India Ltd: key numbers
- Share price
- ₹1,805.95
- Market cap
- ₹4,459 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 45.6×Sector 46.1×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novartis India Ltd
All →Novartis India Management Change
Evonile Pharma (formerly Novartis India) appointed Mr. Gagan Sharma as President – Specialty Business and Senior Management Personnel effective October 26, 2026. The filing is a Regulation 30 senior management appointment intimation.
Novartis India Other Announcement
Novartis India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine periodic disclosure.
Novartis India Annual General Meeting
Evonile Pharma (fka Novartis India) issued a postal ballot notice for shareholder votes on ESOP 2026 grant to the MD & CEO and creation of charge on assets. E-voting runs 14 Oct–12 Nov 2026.
Novartis India Fund Raise of ₹900 Cr
Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.
- Value
- ₹900.0 Cr
Novartis India Credit Rating
Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.
Novartis India Other Announcement
Novartis India Limited has changed its corporate name to Evonile Pharma Limited, effective October 01, 2026, following approval from the Ministry of Corporate Affairs.
Other board meeting date announcements
All →Gujarat Terce Laboratories Board Meeting Date
Gujarat Terce Laboratories will hold a board meeting on November 5, 2026 to consider unaudited standalone results for September 2026. The trading window stays closed until November 7, 2026.
Gautam Gems Board Meeting Date
Gautam Gems Ltd scheduled a board meeting for 3 Nov 2026 to approve Q2 FY27 standalone results. No financial figures or other material decisions are disclosed in this advance intimation.
Gujjubhai Industries Board Meeting Date
Gujjubhai Industries has scheduled its Board meeting for 4 November 2026. The agenda includes approval of unaudited Q1 and H1 FY27 financial results.
The Hi-Tech Gears Board Meeting Date
The Hi-Tech Gears Ltd has scheduled a Board meeting on November 4, 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed.
Cranex Board Meeting Date
Cranex Ltd scheduled a board meeting for 5 Nov 2026 to consider Q2 FY27 financial results. No monetary figures or decisions are disclosed in this advance notice.
Raj Oil Mills Board Meeting Date
Raj Oil Mills Ltd announced its Board Meeting is scheduled for November 5, 2026, to consider unaudited Q1/H1 FY27 financial statements. The trading window for designated persons closed October 1, 2026.